An experimental stroke treatment could save four out of five patients suffering a particularly lethal stroke complication resulting in bleeding in the watery spaces between brain tissue.
Researchers at Johns Hopkins found that administering a clot-busting drug called tissue plasminogen activator (tPA) in these spaces in the brain can cut the death rate from 80 percent to 20 percent.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.